BRCMEDIUM SIGNALFINANCIAL10-K

BRC shows weakening cash generation with operating cash flow declining 29% while working capital expanded substantially across inventory and receivables.

The company appears to be experiencing softer operational performance with reduced cash generation despite increased R&D investment. The substantial reduction in capital expenditure suggests either completed investment cycles or cash preservation measures, while growing working capital indicates either business expansion or collection/inventory management challenges.

Comparing 2025-09-04 vs 2024-09-06View on EDGAR →
FINANCIAL ANALYSIS

BRC's financial position shows mixed signals with operating cash flow declining meaningfully to $181.2M while working capital expanded notably across inventory (+31.5%) and accounts receivable (+25%). The company significantly reduced capital expenditure from $79.9M to $27.6M and moderated share buybacks, while total liabilities grew 20.7% and cash declined 30.3% to $174.3M. This pattern suggests either business growth requiring more working capital investment or operational challenges affecting cash conversion efficiency.

FINANCIAL STATEMENT CHANGES
Capital Expenditure
Cash Flow
-65.5%
$79.9M$27.6M

Capex reduced 65.5% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Interest Expense
P&L
+51.9%
$3.1M$4.7M

Interest expense surged 51.9% — significant debt increase or rising rates materially impacting earnings.

Inventory
Balance Sheet
+31.5%
$152.7M$200.9M

Inventory surged 31.5% — growing faster than typical sales pace; potential demand softening or supply chain overcorrection.

Cash & Equivalents
Balance Sheet
-30.3%
$250.1M$174.3M

Cash declined 30.3% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Share Buybacks
Cash Flow
-29.6%
$72.2M$50.8M

Buyback activity reduced 29.6% — capital being redeployed elsewhere or cash conservation underway.

Operating Cash Flow
Cash Flow
-29%
$255.1M$181.2M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

Accounts Receivable
Balance Sheet
+25%
$185.5M$231.9M

Receivables grew 25% — monitor days sales outstanding for collection efficiency.

Current Liabilities
Balance Sheet
+24.8%
$264.7M$330.3M

Current liabilities rose 24.8% — increased short-term obligations, watch current ratio.

Total Liabilities
Balance Sheet
+20.7%
$448.9M$542.0M

Liabilities increased 20.7% — monitor debt-to-equity ratio and interest coverage.

R&D Expense
P&L
+17.9%
$67.7M$79.9M

R&D investment increased 17.9% — signals commitment to future product development, though near-term margin impact.

LANGUAGE CHANGES
NEW — 2025-09-04
PRIOR — 2024-09-06
ADDED
See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.
As of September 2, 2025, there were 43,555,822 outstanding shares of Class A Nonvoting Common Stock (the Class A Common Stock ), and 3,538,628 shares of Class B Common Stock.
The Americas Asia segment is comprised of our operations in North America, South America and Asia, while the Europe Australia segment is comprised of our operations in Europe, the Middle East, Africa and Australia.
This regional operating structure provides a framework to align local execution with global scale and supports consistent integration of acquired businesses.
Key initiatives in fiscal 2025 included: Investing in organic growth by enhancing our R D process and utilizing customer feedback and observations to develop innovative new products that solve customer needs and improve environmental sustainability.
+7 more — sign up free →
REMOVED
See the definitions of large accelerated filer, accelerated filer, smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
As of September 4, 2024, there were 44,045,649 outstanding shares of Class A Nonvoting Common Stock (the Class A Common Stock ), and 3,538,628 shares of Class B Common Stock.
This regional operating structure allows the Company to further integrate its businesses, support continued growth through the application of the best go-to-market strategies in key geographies, facilitate new product development within recent acquisitions and further simplify and scale the global business.
Our strategy for growth includes an increased focus on certain industries and products, streamlining our product offerings, expanding into higher growth end-markets, improving the overall customer experience, developing technologically advanced, innovative and proprietary products, and improving our digital capabilities.
The following were key initiatives supporting the strategy in fiscal 2024: Investing in organic growth by enhancing our research and development process and utilizing customer feedback and observations to develop innovative new products that solve customer needs and improve environmental sustainability.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →